English
简体中文
Total: £ 56.28
Published Date: 2024-11-25 | Pages: 162 | Tables: 284 | Pharma & Healthcare
The global market for Non-Sterile Liquids and Suspension was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
North American market for Non-Sterile Liquids and Suspension was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Non-Sterile Liquids and Suspension was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Europe market for Non-Sterile Liquids and Suspension was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key companies of Non-Sterile Liquids and Suspension include AbbVie Pharmaceutical Contract Manufacturing, Aenova Group, APPCO Pharmaceutical, Atral Pharmaceutical, Aurigene Pharmaceutical Services (Dr. Reddy’s), Biological E. Ltd., BioPlus Life Sciences, Bora Pharmaceuticals and Cambrex Corporation, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Non-Sterile Liquids and Suspension, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Non-Sterile Liquids and Suspension by region & country, by Type, and by Application.
The Non-Sterile Liquids and Suspension market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Non-Sterile Liquids and Suspension.
Market Segmentation
By Company
AbbVie Pharmaceutical Contract Manufacturing
Aenova Group
APPCO Pharmaceutical
Atral Pharmaceutical
Aurigene Pharmaceutical Services (Dr. Reddy’s)
Biological E. Ltd.
BioPlus Life Sciences
Bora Pharmaceuticals
Cambrex Corporation
COC Farmaceutici
Contract Pharmaceuticals Limited (CPL)
DPT Laboratories
Eurofins
JGL d.d.
Mikart
PharmaVision (Vizyon Holding)
Pierre Fabre
TriRx Pharmaceutical Services
UI Pharmaceuticals
Wasdell Group
Aphena Pharma
Syngene International
Segment by Type:
Oral Liquid
Drops
Other
Segment by Application
Human Medication
Nutraceuticals
Cosmetics
Medical Devices
Veterinary Health
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Non-Sterile Liquids and Suspension manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Non-Sterile Liquids and Suspension in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Non-Sterile Liquids and Suspension in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Market Overview
1.1 Non-Sterile Liquids and Suspension Product Introduction
1.2 Global Non-Sterile Liquids and Suspension Market Size Forecast
1.2.1 Global Non-Sterile Liquids and Suspension Sales Value (2019-2030)
1.2.2 Global Non-Sterile Liquids and Suspension Sales Volume (2019-2030)
1.2.3 Global Non-Sterile Liquids and Suspension Sales Price (2019-2030)
1.3 Non-Sterile Liquids and Suspension Market Trends & Drivers
1.3.1 Non-Sterile Liquids and Suspension Industry Trends
1.3.2 Non-Sterile Liquids and Suspension Market Drivers & Opportunity
1.3.3 Non-Sterile Liquids and Suspension Market Challenges
1.3.4 Non-Sterile Liquids and Suspension Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Non-Sterile Liquids and Suspension Players Revenue Ranking (2023)
2.2 Global Non-Sterile Liquids and Suspension Revenue by Company (2019-2024)
2.3 Global Non-Sterile Liquids and Suspension Players Sales Volume Ranking (2023)
2.4 Global Non-Sterile Liquids and Suspension Sales Volume by Company Players (2019-2024)
2.5 Global Non-Sterile Liquids and Suspension Average Price by Company (2019-2024)
2.6 Key Manufacturers Non-Sterile Liquids and Suspension Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Non-Sterile Liquids and Suspension Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Non-Sterile Liquids and Suspension
2.9 Non-Sterile Liquids and Suspension Market Competitive Analysis
2.9.1 Non-Sterile Liquids and Suspension Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Non-Sterile Liquids and Suspension Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-Sterile Liquids and Suspension as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Oral Liquid
3.1.2 Drops
3.1.3 Other
3.2 Global Non-Sterile Liquids and Suspension Sales Value by Type
3.2.1 Global Non-Sterile Liquids and Suspension Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Non-Sterile Liquids and Suspension Sales Value, by Type (2019-2030)
3.2.3 Global Non-Sterile Liquids and Suspension Sales Value, by Type (%) (2019-2030)
3.3 Global Non-Sterile Liquids and Suspension Sales Volume by Type
3.3.1 Global Non-Sterile Liquids and Suspension Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Non-Sterile Liquids and Suspension Sales Volume, by Type (2019-2030)
3.3.3 Global Non-Sterile Liquids and Suspension Sales Volume, by Type (%) (2019-2030)
3.4 Global Non-Sterile Liquids and Suspension Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Human Medication
4.1.2 Nutraceuticals
4.1.3 Cosmetics
4.1.4 Medical Devices
4.1.5 Veterinary Health
4.2 Global Non-Sterile Liquids and Suspension Sales Value by Application
4.2.1 Global Non-Sterile Liquids and Suspension Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Non-Sterile Liquids and Suspension Sales Value, by Application (2019-2030)
4.2.3 Global Non-Sterile Liquids and Suspension Sales Value, by Application (%) (2019-2030)
4.3 Global Non-Sterile Liquids and Suspension Sales Volume by Application
4.3.1 Global Non-Sterile Liquids and Suspension Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Non-Sterile Liquids and Suspension Sales Volume, by Application (2019-2030)
4.3.3 Global Non-Sterile Liquids and Suspension Sales Volume, by Application (%) (2019-2030)
4.4 Global Non-Sterile Liquids and Suspension Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Non-Sterile Liquids and Suspension Sales Value by Region
5.1.1 Global Non-Sterile Liquids and Suspension Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Non-Sterile Liquids and Suspension Sales Value by Region (2019-2024)
5.1.3 Global Non-Sterile Liquids and Suspension Sales Value by Region (2025-2030)
5.1.4 Global Non-Sterile Liquids and Suspension Sales Value by Region (%), (2019-2030)
5.2 Global Non-Sterile Liquids and Suspension Sales Volume by Region
5.2.1 Global Non-Sterile Liquids and Suspension Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Non-Sterile Liquids and Suspension Sales Volume by Region (2019-2024)
5.2.3 Global Non-Sterile Liquids and Suspension Sales Volume by Region (2025-2030)
5.2.4 Global Non-Sterile Liquids and Suspension Sales Volume by Region (%), (2019-2030)
5.3 Global Non-Sterile Liquids and Suspension Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Non-Sterile Liquids and Suspension Sales Value, 2019-2030
5.4.2 North America Non-Sterile Liquids and Suspension Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Non-Sterile Liquids and Suspension Sales Value, 2019-2030
5.5.2 Europe Non-Sterile Liquids and Suspension Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Non-Sterile Liquids and Suspension Sales Value, 2019-2030
5.6.2 Asia Pacific Non-Sterile Liquids and Suspension Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Non-Sterile Liquids and Suspension Sales Value, 2019-2030
5.7.2 South America Non-Sterile Liquids and Suspension Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Non-Sterile Liquids and Suspension Sales Value, 2019-2030
5.8.2 Middle East & Africa Non-Sterile Liquids and Suspension Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Non-Sterile Liquids and Suspension Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Non-Sterile Liquids and Suspension Sales Value
6.2.1 Key Countries/Regions Non-Sterile Liquids and Suspension Sales Value, 2019-2030
6.2.2 Key Countries/Regions Non-Sterile Liquids and Suspension Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Non-Sterile Liquids and Suspension Sales Value, 2019-2030
6.3.2 United States Non-Sterile Liquids and Suspension Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Non-Sterile Liquids and Suspension Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Non-Sterile Liquids and Suspension Sales Value, 2019-2030
6.4.2 Europe Non-Sterile Liquids and Suspension Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Non-Sterile Liquids and Suspension Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Non-Sterile Liquids and Suspension Sales Value, 2019-2030
6.5.2 China Non-Sterile Liquids and Suspension Sales Value by Type (%), 2023 VS 2030
6.5.3 China Non-Sterile Liquids and Suspension Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Non-Sterile Liquids and Suspension Sales Value, 2019-2030
6.6.2 Japan Non-Sterile Liquids and Suspension Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Non-Sterile Liquids and Suspension Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Non-Sterile Liquids and Suspension Sales Value, 2019-2030
6.7.2 South Korea Non-Sterile Liquids and Suspension Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Non-Sterile Liquids and Suspension Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Non-Sterile Liquids and Suspension Sales Value, 2019-2030
6.8.2 Southeast Asia Non-Sterile Liquids and Suspension Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Non-Sterile Liquids and Suspension Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Non-Sterile Liquids and Suspension Sales Value, 2019-2030
6.9.2 India Non-Sterile Liquids and Suspension Sales Value by Type (%), 2023 VS 2030
6.9.3 India Non-Sterile Liquids and Suspension Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 AbbVie Pharmaceutical Contract Manufacturing
7.1.1 AbbVie Pharmaceutical Contract Manufacturing Company Information
7.1.2 AbbVie Pharmaceutical Contract Manufacturing Introduction and Business Overview
7.1.3 AbbVie Pharmaceutical Contract Manufacturing Non-Sterile Liquids and Suspension Sales, Revenue and Gross Margin (2019-2024)
7.1.4 AbbVie Pharmaceutical Contract Manufacturing Non-Sterile Liquids and Suspension Product Offerings
7.1.5 AbbVie Pharmaceutical Contract Manufacturing Recent Development
7.2 Aenova Group
7.2.1 Aenova Group Company Information
7.2.2 Aenova Group Introduction and Business Overview
7.2.3 Aenova Group Non-Sterile Liquids and Suspension Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Aenova Group Non-Sterile Liquids and Suspension Product Offerings
7.2.5 Aenova Group Recent Development
7.3 APPCO Pharmaceutical
7.3.1 APPCO Pharmaceutical Company Information
7.3.2 APPCO Pharmaceutical Introduction and Business Overview
7.3.3 APPCO Pharmaceutical Non-Sterile Liquids and Suspension Sales, Revenue and Gross Margin (2019-2024)
7.3.4 APPCO Pharmaceutical Non-Sterile Liquids and Suspension Product Offerings
7.3.5 APPCO Pharmaceutical Recent Development
7.4 Atral Pharmaceutical
7.4.1 Atral Pharmaceutical Company Information
7.4.2 Atral Pharmaceutical Introduction and Business Overview
7.4.3 Atral Pharmaceutical Non-Sterile Liquids and Suspension Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Atral Pharmaceutical Non-Sterile Liquids and Suspension Product Offerings
7.4.5 Atral Pharmaceutical Recent Development
7.5 Aurigene Pharmaceutical Services (Dr. Reddy’s)
7.5.1 Aurigene Pharmaceutical Services (Dr. Reddy’s) Company Information
7.5.2 Aurigene Pharmaceutical Services (Dr. Reddy’s) Introduction and Business Overview
7.5.3 Aurigene Pharmaceutical Services (Dr. Reddy’s) Non-Sterile Liquids and Suspension Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Aurigene Pharmaceutical Services (Dr. Reddy’s) Non-Sterile Liquids and Suspension Product Offerings
7.5.5 Aurigene Pharmaceutical Services (Dr. Reddy’s) Recent Development
7.6 Biological E. Ltd.
7.6.1 Biological E. Ltd. Company Information
7.6.2 Biological E. Ltd. Introduction and Business Overview
7.6.3 Biological E. Ltd. Non-Sterile Liquids and Suspension Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Biological E. Ltd. Non-Sterile Liquids and Suspension Product Offerings
7.6.5 Biological E. Ltd. Recent Development
7.7 BioPlus Life Sciences
7.7.1 BioPlus Life Sciences Company Information
7.7.2 BioPlus Life Sciences Introduction and Business Overview
7.7.3 BioPlus Life Sciences Non-Sterile Liquids and Suspension Sales, Revenue and Gross Margin (2019-2024)
7.7.4 BioPlus Life Sciences Non-Sterile Liquids and Suspension Product Offerings
7.7.5 BioPlus Life Sciences Recent Development
7.8 Bora Pharmaceuticals
7.8.1 Bora Pharmaceuticals Company Information
7.8.2 Bora Pharmaceuticals Introduction and Business Overview
7.8.3 Bora Pharmaceuticals Non-Sterile Liquids and Suspension Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Bora Pharmaceuticals Non-Sterile Liquids and Suspension Product Offerings
7.8.5 Bora Pharmaceuticals Recent Development
7.9 Cambrex Corporation
7.9.1 Cambrex Corporation Company Information
7.9.2 Cambrex Corporation Introduction and Business Overview
7.9.3 Cambrex Corporation Non-Sterile Liquids and Suspension Sales, Revenue and Gross Margin (2019-2024)
7.9.4 Cambrex Corporation Non-Sterile Liquids and Suspension Product Offerings
7.9.5 Cambrex Corporation Recent Development
7.10 COC Farmaceutici
7.10.1 COC Farmaceutici Company Information
7.10.2 COC Farmaceutici Introduction and Business Overview
7.10.3 COC Farmaceutici Non-Sterile Liquids and Suspension Sales, Revenue and Gross Margin (2019-2024)
7.10.4 COC Farmaceutici Non-Sterile Liquids and Suspension Product Offerings
7.10.5 COC Farmaceutici Recent Development
7.11 Contract Pharmaceuticals Limited (CPL)
7.11.1 Contract Pharmaceuticals Limited (CPL) Company Information
7.11.2 Contract Pharmaceuticals Limited (CPL) Introduction and Business Overview
7.11.3 Contract Pharmaceuticals Limited (CPL) Non-Sterile Liquids and Suspension Sales, Revenue and Gross Margin (2019-2024)
7.11.4 Contract Pharmaceuticals Limited (CPL) Non-Sterile Liquids and Suspension Product Offerings
7.11.5 Contract Pharmaceuticals Limited (CPL) Recent Development
7.12 DPT Laboratories
7.12.1 DPT Laboratories Company Information
7.12.2 DPT Laboratories Introduction and Business Overview
7.12.3 DPT Laboratories Non-Sterile Liquids and Suspension Sales, Revenue and Gross Margin (2019-2024)
7.12.4 DPT Laboratories Non-Sterile Liquids and Suspension Product Offerings
7.12.5 DPT Laboratories Recent Development
7.13 Eurofins
7.13.1 Eurofins Company Information
7.13.2 Eurofins Introduction and Business Overview
7.13.3 Eurofins Non-Sterile Liquids and Suspension Sales, Revenue and Gross Margin (2019-2024)
7.13.4 Eurofins Non-Sterile Liquids and Suspension Product Offerings
7.13.5 Eurofins Recent Development
7.14 JGL d.d.
7.14.1 JGL d.d. Company Information
7.14.2 JGL d.d. Introduction and Business Overview
7.14.3 JGL d.d. Non-Sterile Liquids and Suspension Sales, Revenue and Gross Margin (2019-2024)
7.14.4 JGL d.d. Non-Sterile Liquids and Suspension Product Offerings
7.14.5 JGL d.d. Recent Development
7.15 Mikart
7.15.1 Mikart Company Information
7.15.2 Mikart Introduction and Business Overview
7.15.3 Mikart Non-Sterile Liquids and Suspension Sales, Revenue and Gross Margin (2019-2024)
7.15.4 Mikart Non-Sterile Liquids and Suspension Product Offerings
7.15.5 Mikart Recent Development
7.16 PharmaVision (Vizyon Holding)
7.16.1 PharmaVision (Vizyon Holding) Company Information
7.16.2 PharmaVision (Vizyon Holding) Introduction and Business Overview
7.16.3 PharmaVision (Vizyon Holding) Non-Sterile Liquids and Suspension Sales, Revenue and Gross Margin (2019-2024)
7.16.4 PharmaVision (Vizyon Holding) Non-Sterile Liquids and Suspension Product Offerings
7.16.5 PharmaVision (Vizyon Holding) Recent Development
7.17 Pierre Fabre
7.17.1 Pierre Fabre Company Information
7.17.2 Pierre Fabre Introduction and Business Overview
7.17.3 Pierre Fabre Non-Sterile Liquids and Suspension Sales, Revenue and Gross Margin (2019-2024)
7.17.4 Pierre Fabre Non-Sterile Liquids and Suspension Product Offerings
7.17.5 Pierre Fabre Recent Development
7.18 TriRx Pharmaceutical Services
7.18.1 TriRx Pharmaceutical Services Company Information
7.18.2 TriRx Pharmaceutical Services Introduction and Business Overview
7.18.3 TriRx Pharmaceutical Services Non-Sterile Liquids and Suspension Sales, Revenue and Gross Margin (2019-2024)
7.18.4 TriRx Pharmaceutical Services Non-Sterile Liquids and Suspension Product Offerings
7.18.5 TriRx Pharmaceutical Services Recent Development
7.19 UI Pharmaceuticals
7.19.1 UI Pharmaceuticals Company Information
7.19.2 UI Pharmaceuticals Introduction and Business Overview
7.19.3 UI Pharmaceuticals Non-Sterile Liquids and Suspension Sales, Revenue and Gross Margin (2019-2024)
7.19.4 UI Pharmaceuticals Non-Sterile Liquids and Suspension Product Offerings
7.19.5 UI Pharmaceuticals Recent Development
7.20 Wasdell Group
7.20.1 Wasdell Group Company Information
7.20.2 Wasdell Group Introduction and Business Overview
7.20.3 Wasdell Group Non-Sterile Liquids and Suspension Sales, Revenue and Gross Margin (2019-2024)
7.20.4 Wasdell Group Non-Sterile Liquids and Suspension Product Offerings
7.20.5 Wasdell Group Recent Development
7.21 Aphena Pharma
7.21.1 Aphena Pharma Company Information
7.21.2 Aphena Pharma Introduction and Business Overview
7.21.3 Aphena Pharma Non-Sterile Liquids and Suspension Sales, Revenue and Gross Margin (2019-2024)
7.21.4 Aphena Pharma Non-Sterile Liquids and Suspension Product Offerings
7.21.5 Aphena Pharma Recent Development
7.22 Syngene International
7.22.1 Syngene International Company Information
7.22.2 Syngene International Introduction and Business Overview
7.22.3 Syngene International Non-Sterile Liquids and Suspension Sales, Revenue and Gross Margin (2019-2024)
7.22.4 Syngene International Non-Sterile Liquids and Suspension Product Offerings
7.22.5 Syngene International Recent Development
8 Industry Chain Analysis
8.1 Non-Sterile Liquids and Suspension Industrial Chain
8.2 Non-Sterile Liquids and Suspension Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Non-Sterile Liquids and Suspension Sales Model
8.5.2 Sales Channel
8.5.3 Non-Sterile Liquids and Suspension Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
Table 1. Non-Sterile Liquids and Suspension Market Trends
Table 2. Non-Sterile Liquids and Suspension Market Drivers & Opportunity
Table 3. Non-Sterile Liquids and Suspension Market Challenges
Table 4. Non-Sterile Liquids and Suspension Market Restraints
Table 5. Global Non-Sterile Liquids and Suspension Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Non-Sterile Liquids and Suspension Revenue Market Share by Company (2019-2024)
Table 7. Global Non-Sterile Liquids and Suspension Sales Volume by Company (2019-2024) & (K Units)
Table 8. Global Non-Sterile Liquids and Suspension Sales Volume Market Share by Company (2019-2024)
Table 9. Global Market Non-Sterile Liquids and Suspension Price by Company (2019-2024) & (US$/Unit)
Table 10. Key Manufacturers Non-Sterile Liquids and Suspension Manufacturing Base Distribution and Headquarters
Table 11. Key Manufacturers Non-Sterile Liquids and Suspension Product Type
Table 12. Key Manufacturers Time to Begin Mass Production of Non-Sterile Liquids and Suspension
Table 13. Global Non-Sterile Liquids and Suspension Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-Sterile Liquids and Suspension as of 2023)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Non-Sterile Liquids and Suspension Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 17. Global Non-Sterile Liquids and Suspension Sales Value by Type (2019-2024) & (US$ Million)
Table 18. Global Non-Sterile Liquids and Suspension Sales Value by Type (2025-2030) & (US$ Million)
Table 19. Global Non-Sterile Liquids and Suspension Sales Market Share in Value by Type (2019-2024) & (%)
Table 20. Global Non-Sterile Liquids and Suspension Sales Market Share in Value by Type (2025-2030) & (%)
Table 21. Global Non-Sterile Liquids and Suspension Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)
Table 22. Global Non-Sterile Liquids and Suspension Sales Volume by Type (2019-2024) & (K Units)
Table 23. Global Non-Sterile Liquids and Suspension Sales Volume by Type (2025-2030) & (K Units)
Table 24. Global Non-Sterile Liquids and Suspension Sales Market Share in Volume by Type (2019-2024) & (%)
Table 25. Global Non-Sterile Liquids and Suspension Sales Market Share in Volume by Type (2025-2030) & (%)
Table 26. Global Non-Sterile Liquids and Suspension Price by Type (2019-2024) & (US$/Unit)
Table 27. Global Non-Sterile Liquids and Suspension Price by Type (2025-2030) & (US$/Unit)
Table 28. Global Non-Sterile Liquids and Suspension Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 29. Global Non-Sterile Liquids and Suspension Sales Value by Application (2019-2024) & (US$ Million)
Table 30. Global Non-Sterile Liquids and Suspension Sales Value by Application (2025-2030) & (US$ Million)
Table 31. Global Non-Sterile Liquids and Suspension Sales Market Share in Value by Application (2019-2024) & (%)
Table 32. Global Non-Sterile Liquids and Suspension Sales Market Share in Value by Application (2025-2030) & (%)
Table 33. Global Non-Sterile Liquids and Suspension Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)
Table 34. Global Non-Sterile Liquids and Suspension Sales Volume by Application (2019-2024) & (K Units)
Table 35. Global Non-Sterile Liquids and Suspension Sales Volume by Application (2025-2030) & (K Units)
Table 36. Global Non-Sterile Liquids and Suspension Sales Market Share in Volume by Application (2019-2024) & (%)
Table 37. Global Non-Sterile Liquids and Suspension Sales Market Share in Volume by Application (2025-2030) & (%)
Table 38. Global Non-Sterile Liquids and Suspension Price by Application (2019-2024) & (US$/Unit)
Table 39. Global Non-Sterile Liquids and Suspension Price by Application (2025-2030) & (US$/Unit)
Table 40. Global Non-Sterile Liquids and Suspension Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Global Non-Sterile Liquids and Suspension Sales Value by Region (2019-2024) & (US$ Million)
Table 42. Global Non-Sterile Liquids and Suspension Sales Value by Region (2025-2030) & (US$ Million)
Table 43. Global Non-Sterile Liquids and Suspension Sales Value by Region (2019-2024) & (%)
Table 44. Global Non-Sterile Liquids and Suspension Sales Value by Region (2025-2030) & (%)
Table 45. Global Non-Sterile Liquids and Suspension Sales Volume by Region (K Units): 2019 VS 2023 VS 2030
Table 46. Global Non-Sterile Liquids and Suspension Sales Volume by Region (2019-2024) & (K Units)
Table 47. Global Non-Sterile Liquids and Suspension Sales Volume by Region (2025-2030) & (K Units)
Table 48. Global Non-Sterile Liquids and Suspension Sales Volume by Region (2019-2024) & (%)
Table 49. Global Non-Sterile Liquids and Suspension Sales Volume by Region (2025-2030) & (%)
Table 50. Global Non-Sterile Liquids and Suspension Average Price by Region (2019-2024) & (US$/Unit)
Table 51. Global Non-Sterile Liquids and Suspension Average Price by Region (2025-2030) & (US$/Unit)
Table 52. Key Countries/Regions Non-Sterile Liquids and Suspension Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 53. Key Countries/Regions Non-Sterile Liquids and Suspension Sales Value, (2019-2024) & (US$ Million)
Table 54. Key Countries/Regions Non-Sterile Liquids and Suspension Sales Value, (2025-2030) & (US$ Million)
Table 55. Key Countries/Regions Non-Sterile Liquids and Suspension Sales Volume, (2019-2024) & (K Units)
Table 56. Key Countries/Regions Non-Sterile Liquids and Suspension Sales Volume, (2025-2030) & (K Units)
Table 57. AbbVie Pharmaceutical Contract Manufacturing Company Information
Table 58. AbbVie Pharmaceutical Contract Manufacturing Introduction and Business Overview
Table 59. AbbVie Pharmaceutical Contract Manufacturing Non-Sterile Liquids and Suspension Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 60. AbbVie Pharmaceutical Contract Manufacturing Non-Sterile Liquids and Suspension Product Offerings
Table 61. AbbVie Pharmaceutical Contract Manufacturing Recent Development
Table 62. Aenova Group Company Information
Table 63. Aenova Group Introduction and Business Overview
Table 64. Aenova Group Non-Sterile Liquids and Suspension Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 65. Aenova Group Non-Sterile Liquids and Suspension Product Offerings
Table 66. Aenova Group Recent Development
Table 67. APPCO Pharmaceutical Company Information
Table 68. APPCO Pharmaceutical Introduction and Business Overview
Table 69. APPCO Pharmaceutical Non-Sterile Liquids and Suspension Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 70. APPCO Pharmaceutical Non-Sterile Liquids and Suspension Product Offerings
Table 71. APPCO Pharmaceutical Recent Development
Table 72. Atral Pharmaceutical Company Information
Table 73. Atral Pharmaceutical Introduction and Business Overview
Table 74. Atral Pharmaceutical Non-Sterile Liquids and Suspension Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 75. Atral Pharmaceutical Non-Sterile Liquids and Suspension Product Offerings
Table 76. Atral Pharmaceutical Recent Development
Table 77. Aurigene Pharmaceutical Services (Dr. Reddy’s) Company Information
Table 78. Aurigene Pharmaceutical Services (Dr. Reddy’s) Introduction and Business Overview
Table 79. Aurigene Pharmaceutical Services (Dr. Reddy’s) Non-Sterile Liquids and Suspension Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 80. Aurigene Pharmaceutical Services (Dr. Reddy’s) Non-Sterile Liquids and Suspension Product Offerings
Table 81. Aurigene Pharmaceutical Services (Dr. Reddy’s) Recent Development
Table 82. Biological E. Ltd. Company Information
Table 83. Biological E. Ltd. Introduction and Business Overview
Table 84. Biological E. Ltd. Non-Sterile Liquids and Suspension Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 85. Biological E. Ltd. Non-Sterile Liquids and Suspension Product Offerings
Table 86. Biological E. Ltd. Recent Development
Table 87. BioPlus Life Sciences Company Information
Table 88. BioPlus Life Sciences Introduction and Business Overview
Table 89. BioPlus Life Sciences Non-Sterile Liquids and Suspension Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 90. BioPlus Life Sciences Non-Sterile Liquids and Suspension Product Offerings
Table 91. BioPlus Life Sciences Recent Development
Table 92. Bora Pharmaceuticals Company Information
Table 93. Bora Pharmaceuticals Introduction and Business Overview
Table 94. Bora Pharmaceuticals Non-Sterile Liquids and Suspension Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 95. Bora Pharmaceuticals Non-Sterile Liquids and Suspension Product Offerings
Table 96. Bora Pharmaceuticals Recent Development
Table 97. Cambrex Corporation Company Information
Table 98. Cambrex Corporation Introduction and Business Overview
Table 99. Cambrex Corporation Non-Sterile Liquids and Suspension Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 100. Cambrex Corporation Non-Sterile Liquids and Suspension Product Offerings
Table 101. Cambrex Corporation Recent Development
Table 102. COC Farmaceutici Company Information
Table 103. COC Farmaceutici Introduction and Business Overview
Table 104. COC Farmaceutici Non-Sterile Liquids and Suspension Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 105. COC Farmaceutici Non-Sterile Liquids and Suspension Product Offerings
Table 106. COC Farmaceutici Recent Development
Table 107. Contract Pharmaceuticals Limited (CPL) Company Information
Table 108. Contract Pharmaceuticals Limited (CPL) Introduction and Business Overview
Table 109. Contract Pharmaceuticals Limited (CPL) Non-Sterile Liquids and Suspension Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 110. Contract Pharmaceuticals Limited (CPL) Non-Sterile Liquids and Suspension Product Offerings
Table 111. Contract Pharmaceuticals Limited (CPL) Recent Development
Table 112. DPT Laboratories Company Information
Table 113. DPT Laboratories Introduction and Business Overview
Table 114. DPT Laboratories Non-Sterile Liquids and Suspension Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 115. DPT Laboratories Non-Sterile Liquids and Suspension Product Offerings
Table 116. DPT Laboratories Recent Development
Table 117. Eurofins Company Information
Table 118. Eurofins Introduction and Business Overview
Table 119. Eurofins Non-Sterile Liquids and Suspension Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 120. Eurofins Non-Sterile Liquids and Suspension Product Offerings
Table 121. Eurofins Recent Development
Table 122. JGL d.d. Company Information
Table 123. JGL d.d. Introduction and Business Overview
Table 124. JGL d.d. Non-Sterile Liquids and Suspension Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 125. JGL d.d. Non-Sterile Liquids and Suspension Product Offerings
Table 126. JGL d.d. Recent Development
Table 127. Mikart Company Information
Table 128. Mikart Introduction and Business Overview
Table 129. Mikart Non-Sterile Liquids and Suspension Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 130. Mikart Non-Sterile Liquids and Suspension Product Offerings
Table 131. Mikart Recent Development
Table 132. PharmaVision (Vizyon Holding) Company Information
Table 133. PharmaVision (Vizyon Holding) Introduction and Business Overview
Table 134. PharmaVision (Vizyon Holding) Non-Sterile Liquids and Suspension Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 135. PharmaVision (Vizyon Holding) Non-Sterile Liquids and Suspension Product Offerings
Table 136. PharmaVision (Vizyon Holding) Recent Development
Table 137. Pierre Fabre Company Information
Table 138. Pierre Fabre Introduction and Business Overview
Table 139. Pierre Fabre Non-Sterile Liquids and Suspension Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 140. Pierre Fabre Non-Sterile Liquids and Suspension Product Offerings
Table 141. Pierre Fabre Recent Development
Table 142. TriRx Pharmaceutical Services Company Information
Table 143. TriRx Pharmaceutical Services Introduction and Business Overview
Table 144. TriRx Pharmaceutical Services Non-Sterile Liquids and Suspension Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 145. TriRx Pharmaceutical Services Non-Sterile Liquids and Suspension Product Offerings
Table 146. TriRx Pharmaceutical Services Recent Development
Table 147. UI Pharmaceuticals Company Information
Table 148. UI Pharmaceuticals Introduction and Business Overview
Table 149. UI Pharmaceuticals Non-Sterile Liquids and Suspension Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 150. UI Pharmaceuticals Non-Sterile Liquids and Suspension Product Offerings
Table 151. UI Pharmaceuticals Recent Development
Table 152. Wasdell Group Company Information
Table 153. Wasdell Group Introduction and Business Overview
Table 154. Wasdell Group Non-Sterile Liquids and Suspension Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 155. Wasdell Group Non-Sterile Liquids and Suspension Product Offerings
Table 156. Wasdell Group Recent Development
Table 157. Aphena Pharma Company Information
Table 158. Aphena Pharma Introduction and Business Overview
Table 159. Aphena Pharma Non-Sterile Liquids and Suspension Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 160. Aphena Pharma Non-Sterile Liquids and Suspension Product Offerings
Table 161. Aphena Pharma Recent Development
Table 162. Syngene International Company Information
Table 163. Syngene International Introduction and Business Overview
Table 164. Syngene International Non-Sterile Liquids and Suspension Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 165. Syngene International Non-Sterile Liquids and Suspension Product Offerings
Table 166. Syngene International Recent Development
Table 167. Key Raw Materials Lists
Table 168. Raw Materials Key Suppliers Lists
Table 169. Non-Sterile Liquids and Suspension Downstream Customers
Table 170. Non-Sterile Liquids and Suspension Distributors List
Table 171. Research Programs/Design for This Report
Table 172. Key Data Information from Secondary Sources
Table 173. Key Data Information from Primary Sources
List of Figures
Figure 1. Non-Sterile Liquids and Suspension Product Picture
Figure 2. Global Non-Sterile Liquids and Suspension Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Non-Sterile Liquids and Suspension Sales Value (2019-2030) & (US$ Million)
Figure 4. Global Non-Sterile Liquids and Suspension Sales Volume (2019-2030) & (K Units)
Figure 5. Global Non-Sterile Liquids and Suspension Sales Price (2019-2030) & (US$/Unit)
Figure 6. Non-Sterile Liquids and Suspension Report Years Considered
Figure 7. Global Non-Sterile Liquids and Suspension Players Revenue Ranking (2023) & (US$ Million)
Figure 8. Global Non-Sterile Liquids and Suspension Players Sales Volume Ranking (2023) & (K Units)
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Non-Sterile Liquids and Suspension Revenue in 2023
Figure 10. Non-Sterile Liquids and Suspension Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 11. Oral Liquid Picture
Figure 12. Drops Picture
Figure 13. Other Picture
Figure 14. Global Non-Sterile Liquids and Suspension Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 15. Global Non-Sterile Liquids and Suspension Sales Value Market Share by Type, 2023 & 2030
Figure 16. Global Non-Sterile Liquids and Suspension Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)
Figure 17. Global Non-Sterile Liquids and Suspension Sales Volume Market Share by Type, 2023 & 2030
Figure 18. Global Non-Sterile Liquids and Suspension Price by Type (2019-2030) & (US$/Unit)
Figure 19. Product Picture of Human Medication
Figure 20. Product Picture of Nutraceuticals
Figure 21. Product Picture of Cosmetics
Figure 22. Product Picture of Medical Devices
Figure 23. Product Picture of Veterinary Health
Figure 24. Global Non-Sterile Liquids and Suspension Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 25. Global Non-Sterile Liquids and Suspension Sales Value Market Share by Application, 2023 & 2030
Figure 26. Global Non-Sterile Liquids and Suspension Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)
Figure 27. Global Non-Sterile Liquids and Suspension Sales Volume Market Share by Application, 2023 & 2030
Figure 28. Global Non-Sterile Liquids and Suspension Price by Application (2019-2030) & (US$/Unit)
Figure 29. North America Non-Sterile Liquids and Suspension Sales Value (2019-2030) & (US$ Million)
Figure 30. North America Non-Sterile Liquids and Suspension Sales Value by Country (%), 2023 VS 2030
Figure 31. Europe Non-Sterile Liquids and Suspension Sales Value (2019-2030) & (US$ Million)
Figure 32. Europe Non-Sterile Liquids and Suspension Sales Value by Country (%), 2023 VS 2030
Figure 33. Asia Pacific Non-Sterile Liquids and Suspension Sales Value (2019-2030) & (US$ Million)
Figure 34. Asia Pacific Non-Sterile Liquids and Suspension Sales Value by Country (%), 2023 VS 2030
Figure 35. South America Non-Sterile Liquids and Suspension Sales Value (2019-2030) & (US$ Million)
Figure 36. South America Non-Sterile Liquids and Suspension Sales Value by Country (%), 2023 VS 2030
Figure 37. Middle East & Africa Non-Sterile Liquids and Suspension Sales Value (2019-2030) & (US$ Million)
Figure 38. Middle East & Africa Non-Sterile Liquids and Suspension Sales Value by Country (%), 2023 VS 2030
Figure 39. Key Countries/Regions Non-Sterile Liquids and Suspension Sales Value (%), (2019-2030)
Figure 40. Key Countries/Regions Non-Sterile Liquids and Suspension Sales Volume (%), (2019-2030)
Figure 41. United States Non-Sterile Liquids and Suspension Sales Value, (2019-2030) & (US$ Million)
Figure 42. United States Non-Sterile Liquids and Suspension Sales Value by Type (%), 2023 VS 2030
Figure 43. United States Non-Sterile Liquids and Suspension Sales Value by Application (%), 2023 VS 2030
Figure 44. Europe Non-Sterile Liquids and Suspension Sales Value, (2019-2030) & (US$ Million)
Figure 45. Europe Non-Sterile Liquids and Suspension Sales Value by Type (%), 2023 VS 2030
Figure 46. Europe Non-Sterile Liquids and Suspension Sales Value by Application (%), 2023 VS 2030
Figure 47. China Non-Sterile Liquids and Suspension Sales Value, (2019-2030) & (US$ Million)
Figure 48. China Non-Sterile Liquids and Suspension Sales Value by Type (%), 2023 VS 2030
Figure 49. China Non-Sterile Liquids and Suspension Sales Value by Application (%), 2023 VS 2030
Figure 50. Japan Non-Sterile Liquids and Suspension Sales Value, (2019-2030) & (US$ Million)
Figure 51. Japan Non-Sterile Liquids and Suspension Sales Value by Type (%), 2023 VS 2030
Figure 52. Japan Non-Sterile Liquids and Suspension Sales Value by Application (%), 2023 VS 2030
Figure 53. South Korea Non-Sterile Liquids and Suspension Sales Value, (2019-2030) & (US$ Million)
Figure 54. South Korea Non-Sterile Liquids and Suspension Sales Value by Type (%), 2023 VS 2030
Figure 55. South Korea Non-Sterile Liquids and Suspension Sales Value by Application (%), 2023 VS 2030
Figure 56. Southeast Asia Non-Sterile Liquids and Suspension Sales Value, (2019-2030) & (US$ Million)
Figure 57. Southeast Asia Non-Sterile Liquids and Suspension Sales Value by Type (%), 2023 VS 2030
Figure 58. Southeast Asia Non-Sterile Liquids and Suspension Sales Value by Application (%), 2023 VS 2030
Figure 59. India Non-Sterile Liquids and Suspension Sales Value, (2019-2030) & (US$ Million)
Figure 60. India Non-Sterile Liquids and Suspension Sales Value by Type (%), 2023 VS 2030
Figure 61. India Non-Sterile Liquids and Suspension Sales Value by Application (%), 2023 VS 2030
Figure 62. Non-Sterile Liquids and Suspension Industrial Chain
Figure 63. Non-Sterile Liquids and Suspension Manufacturing Cost Structure
Figure 64. Channels of Distribution (Direct Sales, and Distribution)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
